2 AZARGA er ikke undersøgt hos patienter med svært nedsat nyrefunktion (creatinin- clearance < 30 ml/ min) eller hos patienter med hyperchloræmisk acidose.
AZARGA has not been studied in patients with severe renal impairment (creatinine clearance < 30 ml/ min) or in patients with hyperchloraemic acidosis.